Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Folic acid supplementation to reduce cardiovascular risk in liver transplant recipients with hyperhomocysteinaemia
2005-005178-55Phase 4Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of folinic acid in hyperhomocysteinemia and cardiac morbidity, sponsored by Sant'Orsola-Malpighi University Hospital. Primary endpoints: Change in plasma homocysteine levels and Plasma folic acid levels. Started Mar 2007; status: completed.
02
Drugs
folinic acid
03
Conditions
hyperhomocysteinemiacardiac morbidity
Beyond the preview
Go deeper on 2005-005178-55.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-005178-55.